The 20 Best COVID-19 Doctors near Randallstown, MD

Dr. Robin Avery is an infectious disease physician who joined the Johns Hopkins faculty in 2012, with two decades of experience in transplant infectious disease. She is a past chair of the American Society of Transplantation (AST) Infectious Disease Community of Practice, was a co-editor of the first edition of the AST ID Guidelines, and serves on a Guidelines Committee for the Infectious Disease Society of America (IDSA) on immunizations in the immunocompromised host. She was the founding head of the Transplant Infectious Disease Section at the Cleveland Clinic and served as the founding director of the Cleveland Clinic Transplant ID Special Fellowship, authoring a curriculum that served as the basis for curricula later endorsed by the AST and IDSA. Her clinical and research interests include pre-transplant donor and recipient evaluation, and prevention and treatment of post-transplant infections, particularly transplant-associated viruses, viral load monitoring, novel therapies for CMV, hypogammaglobulinemia, immunizations, and strategies for safer living post-transplant. She has a strong interest in patient education and co-authored the script for a video designed to educate patients on decreasing post-transplant infection risks. Dr. Avery is rated as a Distinguished provider by MediFind in the treatment of COVID-19. Her top areas of expertise are Cytomegalic Inclusion Disease, Cytomegalovirus Infection, COVID-19, and Sepsis.

Paul Gurbel is a Cardiologist in Baltimore, Maryland. Dr. Gurbel is rated as a Distinguished provider by MediFind in the treatment of COVID-19. His top areas of expertise are Acute Coronary Syndrome, Coronary Heart Disease, Heart Attack, Percutaneous Coronary Intervention (PCI), and Angioplasty.

Kinjal Sheth is an Intensive Care Medicine provider in Randallstown, Maryland. Dr. Sheth is rated as an Experienced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Pneumonia, Liver Failure, COVID-19, Gastrostomy, and Endoscopy.

Dr. Andrea L. Cox is a professor of Internal Medicine at the Johns Hopkins University School of Medicine in the Division of Infectious Diseases and is a member of the Johns Hopkins Kimmel Cancer Center. She holds joint appointments in Oncology and at the Johns Hopkins Bloomberg School of Public Health, in Molecular Microbiology and Immunology. She is an internationally recognized leader in studies of immune responses in immunocompetent and immunocompromised patient populations to viral infections and vaccines against them, including SARS-Co-V-2 (the virus that causes COVID-19), HIV, hepatitis B virus (HBV) and hepatitis C virus (HCV). Dr. Cox earned her Ph.D. in chemistry from the University of Virginia, where she characterized peptides that drive T cell responses. She then earned her M.D. and completed internal medicine residency and infectious disease fellowship training at Johns Hopkins. She leads the largest prospective cohort study of acute HCV infection, designed to enable detailed molecular analysis of HCV transmission, host immune responses, and virus sequence evolution. She co-led the first prophylactic HCV vaccine trial in individuals at risk of HCV infection. She leads a multidisciplinary international team investigating HCV-specific immune responses to improve vaccine development against HCV, is the lead immunologist on a clinical trial of HBV vaccines in people living with HIV, and co-leads a large team investigating immune responses to COVID-19 infection and vaccines. In addition to her research on viral infections and vaccines, Dr. Cox is actively involved in clinical care of patients with HCV, HIV, and HBV infections. Dr. Cox serves as the director of the Medical Scientist Training Program. A teacher, advisor, and mentor of physician-scientists and scientists, Dr. Cox mentors Ph.D. students in the Johns Hopkins Cellular and Molecular Medicine, Molecular Microbiology and Immunology, and the Immunology graduate training programs. Dr. Cox is rated as an Advanced provider by MediFind in the treatment of COVID-19. Her top areas of expertise are Hepatitis C, Hepatitis, Severe Acute Respiratory Syndrome (SARS), and COVID-19.

Dr. Erin D. Michos is a Professor of Medicine within the Division of Cardiology at Johns Hopkins School of Medicine, with joint appointment in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Director of Women's Cardiovascular Health and the Associate Director of Preventive Cardiology within the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. Dr. Michos is an internationally known expert in Preventive Cardiology and Women’s Health, having authored >700 publications and 11 book chapters. Her research involves (1) Women’s Cardiovascular Health; (2) Lipids and Lipid management; (3) Cardio-Kidney-Metabolic and Obesity disease management (4) Coronary artery calcium, inflammation and biomarkers of cardiovascular risk. She is the co-Editor-in-Chief for the American Journal of Preventive Cardiology. She is Co-Director of the IMPACT Center (Improving Participation Among Diverse Populations in Cardiovascular Clinical Trials) at Johns Hopkins, funded by the American Heart Association (AHA). She is a co-investigator in several NIH-funded studies including the Multi-Ethnic Study of Atherosclerosis and Atherosclerosis Risk in Communities cohorts. She has served as the Training Director for four AHA Strategic Focused Research Networks. She has mentored over 60 individuals and the recipient of 2 mentoring awards. Additionally, she was the recipient of the Nanette Wegner Award for Women’s Health Medical Leadership by the Women Heart Organization and the Donna Vogel Women’s Health Champion Award by Johns Hopkins University. Dr. Michos completed medical school at Northwestern University, Internal Medicine residency and Cardiology fellowship at the Johns Hopkins Hospital, and a Masters of Health Science degree at the Johns Hopkins Bloomberg School of Public Health. Dr. Michos is rated as an Advanced provider by MediFind in the treatment of COVID-19. Her top areas of expertise are Atherosclerosis, Vitamin D Deficiency, Heart Failure, Percutaneous Coronary Intervention (PCI), and Thrombectomy.

Dr. Wendy Post is professor of medicine at the Johns Hopkins University School of Medicine and holds a joint appointment as professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Lou and Nancy Grasmick Professor of Cardiology. Dr. Post is a cardiologist at the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease and the Echocardiography Laboratory and is associate faculty at the Welch Center for Prevention, Epidemiology, and Clinical Research at Johns Hopkins University. She is Director of Cardiovascular Research for the Division of Cardiology and Director of Research for the Hopkins Cardiovascular Fellowship Training Program. Dr. Post received her undergraduate degree in biology from Harvard University. She earned her medical degree from Columbia College of Surgeons and Physicians, Columbia University. After completing her internship and residency at Harvard Medical School’s Beth Israel Hospital, Dr. Post received her master’s degree in epidemiology from the Harvard School of Public Health. She was a research fellow at the Framingham Heart Study, in Framingham, Mass., and completed a fellowship in cardiology at The Johns Hopkins Hospital. Dr. Post joined the Johns Hopkins faculty in 1997. Dr. Post’s research interests include prediction and prevention of coronary heart disease and sudden cardiac death, noninvasive imaging of subclinical atherosclerosis, genetics of cardiovascular disease, sex and racial/ethnic differences in cardiovascular disease, and cardiovascular disease in HIV/AIDS and COVID-19. She is the chair of the steering committee, and the principal investigator for the Hopkins field center for the NIH-funded Multi-Ethnic Study of Atherosclerosis (MESA). Dr. Post also leads Multicenter AIDS Cohort Study (MACS) Cardiovascular Disease sub-studies. She has been the PI for three R01 grants from NHLBI investigating cardiovascular disease in HIV, and is dual PI on the cardiology NHLBI training grant, which has been continuously funded for over 45 years. Dr. Post is a manuscript reviewer for multiple publications and is currently associate editor of Circulation. She has over 350 peer-reviewed research publications. Dr. Post was elected as a member of the American Society for Clinical Investigation (ASCI) in 2015. She mentors multiple medical students, medical house staff, fellows and junior faculty. She was a member of the Hopkins Professorial Promotions Committee and a former Johns Hopkins University Provost Fellow. She was co-chair of the Johns Hopkins University Committee on the Biomedical Scientific Workforce. Dr. Post is rated as an Advanced provider by MediFind in the treatment of COVID-19. Her top areas of expertise are Atherosclerosis, Coronary Heart Disease, Carotid Artery Disease, Hormone Replacement Therapy (HRT), and Aortic Valve Replacement.

Dr. Christine Durand, associate professor of medicine and oncology and member of the Johns Hopkins Kimmel Cancer Center, is involved in clinical and translational research focused on individuals infected with HIV and hepatitis C virus who require cancer and transplant therapies. Her current research efforts include looking at outcomes of hepatitis C treatment after solid organ transplant, the potential use of organs from HIV-infected donors for HIV-infected solid organ transplant candidates, and HIV cure strategies including bone marrow transplantation. Dr. Durand is rated as an Advanced provider by MediFind in the treatment of COVID-19. Her top areas of expertise are HIV/AIDS, Hepatitis C, Hepatitis, Tissue Biopsy, and Nephrectomy.

Daniel Brodie is an Intensive Care Medicine specialist and a Pulmonary Medicine provider in Baltimore, Maryland. Dr. Brodie is rated as a Distinguished provider by MediFind in the treatment of COVID-19. His top areas of expertise are Acute Respiratory Distress Syndrome (ARDS), Respiratory Acidosis, COVID-19, Lung Transplant, and Embolectomy.

Dr. Hager is a specialist in Critical Care Medicine. He is an expert in the diagnosis and management of all forms of acute respiratory failure, including asthma, pneumonia, C.O.P.D., neuromuscular diseases, and the acute respiratory distress syndrome. He also has extensive experience in the management of other life-threatening conditions such as pulmonary embolism, gastrointestinal hemorrhage, shock from sepsis, hypovolemia, and heart disease, and metabolic emergencies such as diabetic ketoacidosis and hyperosmolar states. Dr. Hager is rated as a Distinguished provider by MediFind in the treatment of COVID-19. His top areas of expertise are Severe Acute Respiratory Syndrome (SARS), COVID-19, Cerebral Hypoxia, and Acute Respiratory Distress Syndrome (ARDS).

Dr. Werbel is a physician-scientist who provides consultative care for patients at Johns Hopkins who experience infectious disease complications before and after organ transplant, as well as in the setting of solid tumors or blood cancers. His research with the Johns Hopkins Transplant Research Center uses a combination of epidemiological and laboratory methods to better personalize the prevention of infectious complications among patients with complex immunodeficiencies. This includes using national cohort studies and clinical trials to optimize the use of vaccines and other prophylactic therapies for high-risk immunosuppressed populations. Dr. Werbel is rated as a Distinguished provider by MediFind in the treatment of COVID-19. His top areas of expertise are COVID-19, Severe Acute Respiratory Syndrome (SARS), HIV/AIDS, and Hepatitis.

Ramaswamy Rangarajan is a primary care provider, practicing in Hospital Medicine in Randallstown, Maryland. Dr. Rangarajan is rated as an Advanced provider by MediFind in the treatment of COVID-19. His top areas of expertise are COVID-19, Multisystem Inflammatory Syndrome in Children (MIS-C), Dehydration, Gastrostomy, and Colonoscopy.

Allan Chircus is a primary care provider, practicing in Family Medicine in Randallstown, Maryland. Dr. Chircus is rated as an Advanced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Peptic Ulcer, Cellulitis, Necrosis, and Otitis.

Trung Pham is a primary care provider, practicing in Internal Medicine in Randallstown, Maryland. Dr. Pham is rated as an Advanced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Hypertension, Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, and Vitamin D Deficiency.

Jason Federline is a primary care provider, practicing in Family Medicine in Owings Mills, Maryland. Dr. Federline is rated as an Advanced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Bronchitis, Otitis, COVID-19, and Multisystem Inflammatory Syndrome in Children (MIS-C).

Dana Bebu is a primary care provider, practicing in Internal Medicine in Owings Mills, Maryland. Dr. Bebu is rated as an Advanced provider by MediFind in the treatment of COVID-19. Her top areas of expertise are Flu, Acute Cystitis, COVID-19, and Multisystem Inflammatory Syndrome in Children (MIS-C).

Elena Sabaeva is a primary care provider, practicing in Internal Medicine in Pikesville, Maryland. Dr. Sabaeva is rated as an Advanced provider by MediFind in the treatment of COVID-19. Her top areas of expertise are Bronchitis, Acute Cystitis, COVID-19, and Multisystem Inflammatory Syndrome in Children (MIS-C).

Eyad Cheikh, M.D. received his medical degree from the University of Damascus School of Medicine. He completed residency training in Internal Medicine at Saint Agnes Hospital in Baltimore, and finished his fellowship in Infectious Diseases at Carilion Clinic in Carilion Roanoke Memorial Hospital. Dr. Cheikh's areas of interest include general Infectious Diseases, HIV care and infection control. Learn more at idmaryland.com. Dr. Cheikh is rated as an Experienced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Sepsis, Hospital-Acquired Pneumonia, Pneumonia, and COVID-19.

Robert Ross, M.D. received his medical degree from the Oregon Health and Science University in Portland, Oregon. He completed an Internal Medicine residency at the University of Maryland Medical System. Dr. Ross completed his training with an Infectious Diseases fellowship at the National Institutes of Health. While at the NIH, Dr. Ross was part of the research programs at the NIAID HIV research clinic and the Vaccine Research Center. His areas of interest are HIV care, orthopedic infections and general Infectious Diseases. Learn more at idmaryland.com. Dr. Ross is rated as an Experienced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Sepsis, Infectious Arthritis, Lymphangitis, and Osteomyelitis.

Motti Mulleta is a primary care provider, practicing in Internal Medicine in Catonsville, Maryland. Dr. Mulleta is rated as a Distinguished provider by MediFind in the treatment of COVID-19. His top areas of expertise are Atypical Pneumonia, Hospital-Acquired Pneumonia, Acute Cystitis, and Bronchitis.

Jeffrey Brauer is an Intensive Care Medicine provider in Baltimore, Maryland. Dr. Brauer is rated as an Advanced provider by MediFind in the treatment of COVID-19. His top areas of expertise are COVID-19, Pneumonia, Pleurisy, Gastrostomy, and Endoscopy.